Clinical trial
Clinical Study of OncoSorb® in Patients With Advanced Cancer Entities
NCT01013168 is registered in ClinicalTrials.gov with BioPheresis GmbH as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Study of OncoSorb® in Patients With Advanced Cancer Entities
- Lead sponsor
- BioPheresis GmbH
- Phase
- Phase 1/2
- Overall status
- Terminated
- Start date
- August 31, 2009
- Completion date
- February 28, 2011
- Enrollment
- 4 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
advanced cancer entities